Discover the captivating world of Smith & Sheridan
With years of experience in the fields of biotech and pharma, Smith & Sheridan bring a wealth of expertise to each podcast episode. We are committed to delivering high-quality content that informs, inspires, and engages our listeners.
At Smith & Sheridan, our motivation is to foster a community of avid listeners who are passionate about the world of Biotechnology. We strive to create podcasts that not only entertain but also educate, allowing our audience to stay up-to-date and connected to the latest developments in the industry.
Since the 1990s, Smith & Sheridan have interviewed and conversed with thousands of international professionals in the biotech and pharma industry. Both have written, taught, and advised on the sector.
Your Hosts
Cormac Sheridan
Cormac Sheridan is a highly experienced biotechnology commentator, having reported on the sector since the mid-1990s. He has been a contributor to Nature Biotechnology for over two decades and reported for BioWorld for over 25 years. His work has also appeared in Nature Reviews Drug Discovery, The Scientist, New Scientist, The Irish Times, The Irish Examiner, and Technology Ireland, among other publications. He has also reported on technology for IT’s Monday News and has lectured on media to B.Sc. Genetics students at University College Cork for 20 years.
Cormac studied Microbiology at UCC and Journalism at Dublin City University and is currently the pro bono administrator of the Mary Mulvihill Award, a science media competition for third-level students in Ireland. In a previous life, he was a theatre lighting designer.
Andy Smith
Andy Smith gives an analyst and investor’s view on life science companies. He has been the lead fund manager for four life science–specific funds, including 3i Bioscience, International Biotechnology and the AXA Framlington Biotech Fund, and was chief investment officer at Mannbio Invest. He was a global product manager at SmithKline Beecham Pharmaceuticals until 2000.
Andy joined the independent research house Equity Development in 2019 having previously been an analyst at Edison group and a Senior Principal in ICON PLC’s Commercialization, Pricing and Market Access consulting practice.
Our Core Values
At Smith & Sheridan, we uphold the following values to guide our work and interactions with our audience:
Excellence
We strive for excellence in every podcast episode, ensuring meticulous research, engaging content, and high production quality.
Innovation
We are committed to embracing innovation and exploring cutting-edge topics, pushing the boundaries of knowledge in the fields of biotech and pharma.
Community
We believe in fostering a strong community of listeners who can connect, learn, and grow together in their passion for biotech and pharma.
